In a recent study, a panel of six biomarkers including inflammatory markers, HDL cholesterol, IGFBP-2 and adiponectin improved prediction of future T2D when added to a clinical model including HbA1c, which was used instead of fasting glucose and insulin (29). The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.